Jeffrey N. Weitzel

Best Publications

• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

  Andrew Tutt;Mark Robson;Judy E Garber;Susan M Domchek

  2183
  Citations

• Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

  Susan M. Domchek;Tara M. Friebel;Christian F. Singer;D. Gareth Evans

  1627
  Citations

• Breast-Cancer Risk in Families with Mutations in PALB2

  A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale

  1023
  Citations

• Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021

  Mary B. Daly;Tuya Pal;Michael P. Berry;Saundra S. Buys

  868
  Citations

• Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations

  Kelly D. Gonzalez;Katie A. Noltner;Carolyn H. Buzin;Dongqing Gu

  775
  Citations

• Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation

  Amy Finch;Mario Beiner;Jan Lubinski;Henry T. Lynch

  754
  Citations

• Cancer health disparities in racial/ethnic minorities in the United States

  Valentina A Zavala;Paige M Bracci;John M Carethers;Luis Carvajal-Carmona

  661
  Citations

• Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

  Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  643
  Citations

• ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes

  José G. Guillem;William C. Wood;Jeffrey F. Moley;Andrew Berchuck

  614
  Citations

• A Population-Based Study of Genes Previously Implicated in Breast Cancer

  Chunling Hu;Steven N Hart;Rohan Gnanaolivu;Hongyan Huang

  587
  Citations

• NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

  Mary B. Daly;Robert Pilarski;Michael Berry;Saundra S. Buys

  555
  Citations

• Genetic/familial high-risk assessment: breast and ovarian.

  Mary B. Daly;Jennifer E. Axilbund;Saundra Buys;Beth Crawford

  525
  Citations

• Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

  Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova

  513
  Citations

• Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

  Steven A. Narod;Marie Pierre Dubé;Jan Klijn;Jan Lubinski

  468
  Citations

• NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

  Mary B. Daly;Robert Pilarski;Matthew B. Yurgelun;Michael P. Berry

  459
  Citations

• Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

  Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  457
  Citations

• A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

  Antonis C. Antoniou;Xianshu Wang;Zachary S. Fredericksen;Lesley McGuffog

  404
  Citations

• Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

  Roger L Milne;Roger L Milne;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Kyriaki Michailidou;Kyriaki Michailidou;Jonathan Beesley

  376
  Citations

• Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

  Antonis C. Antoniou;Antonis C. Antoniou;Amanda B. Spurdle;Amanda B. Spurdle;Olga M. Sinilnikova;Olga M. Sinilnikova;Sue Healey;Sue Healey

  375
  Citations

• Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

  Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

  372
  Citations